<- Go Home
Cryo-Cell International, Inc.
Cryo-Cell International, Inc. engages in cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells, which are used in regenerative medicine to treat a range of conditions. The company manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.
Market Cap
$36.4M
Volume
14.5K
Cash and Equivalents
$265.2K
EBITDA
$5.3M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$24.5M
Profit Margin
77.07%
52 Week High
$9.43
52 Week Low
$4.09
Dividend
N/A
Price / Book Value
-2.45
Price / Earnings
-76.94
Price / Tangible Book Value
-2.06
Enterprise Value
$45.7M
Enterprise Value / EBITDA
7.89
Operating Income
$4.3M
Return on Equity
3.88%
Return on Assets
4.29
Cash and Short Term Investments
$3.2M
Debt
$12.6M
Equity
-$14.8M
Revenue
$31.7M
Unlevered FCF
$4.4M
Sector
Health Care Providers and Services
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium